Hua Medicine (Shanghai) Ltd. (2552.HK) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Hua Medicine (Shanghai) Ltd., with annual and quarterly history.
| Metric | 2025 |
|---|---|
| Valuation | |
| P/E Ratio | 2.54x |
| P/B Ratio | 2.71x |
| P/S Ratio | 5.69x |
| Profitability | |
| Gross Margin | 56.9% |
| Operating Margin | -29.4% |
| Net Margin | 224.4% |
| EBITDA Margin | -22.8% |
| Liquidity | |
| Current Ratio | 6.17x |
| Quick Ratio | 5.59x |
| Leverage | |
| Debt/Equity | 0.30x |
YoY = year-over-year change. Source: FMP..